Vomicine

CAS : 125-15-5

Ref. 3D-AAA12515

Informations sur le produit

• Nom: Vomicine
• Synonymes: (4aR,6aS,12aS,12bR,12cS)-10-hydroxy-15-methyl-4a,5,12,12a,12b,12c-hexahydro-11H-6a,4-(ethanoiminomethano)-1-oxa-10b-azacyclohepta[1,2,3-cd]fluoranthene-6,11(2H)-dione, (4aR,6aS,13aS,13bR,13cS)-4a,5,13,13a,13b,13c-Hexahydro-10-hydroxy-16-methyl-12H-6a,4-(ethaniminomethano)indolo[3,2,1-ij]oxepino[2,3,4-de]quinoline-6,12(2H)-dione, 12-Hydroxyicajine, 12H-6a,4-(Ethaniminomethano)indolo(3,2,1-i)oxepino(2,3,4-de)quinoline-6,12(2H)-dione, 4a,5,13,13a,13b,13c-hedahydro-10-hydroxy-16-methyl-, (4aR,6aS,13aS,13bR,13cS)-, 12H-6a,4-(Ethaniminomethano)indolo[3,2,1-ij]oxepino[2,3,4-de]quinoline-6,12(2H)-dione, 4a,5,13,13a,13b,13c-hexahydro-10-hydroxy-16-methyl-, (4aR,6aS,13aS,13bR,13cS)-, 12H-6a,4-(Ethaniminomethano)indolo[3,2,1-ij]oxepino[2,3,4-de]quinoline-6,12(2H)-dione, 4a,5,13,13a,13b,13c-hexahydro-10-hydroxy-16-methyl-, [4aR-(4aR*,6aS*,13aS*,13bR*,13cS*)]-, 16,19-Secostrychnidine-10,16-dione, 4-hydroxy-19-methyl-, 2H-6a,4-(Ethaniminomethano)indolo(3,2,1-i)oxepino(2,3,4-de)quinoline-6,12(2H)-dione, 4a,5,13,13a,13b,13c-hedahydro-10-hydroxy-16-methyl-, (4aR-(4aR*,6aS*,13aS*,13bR*,13cS*))-, 4-Hydroxy-19-methyl-16,19-secostrychnidine-10,16-dione, Strychnicine, Vomicin

Description

Vomicine is an inhibitor of the Chinese hamster ovary cell potassium channel and human kinase. It has been shown to have anticancer properties, inhibiting cancer cell growth and inducing apoptosis. Vomicine is an analog of heparin and has been found in the urine of tumor-bearing animals. This compound has also been shown to inhibit chitin synthase, which may contribute to its anticancer effects. In addition, vomicine has potential as a therapeutic agent for cancer treatment due to its ability to act as a kinase inhibitor. Overall, vomicine shows promise as a potent and effective anticancer agent with multiple mechanisms of action.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 380.4 g/mol
• Formule: C₂₂H₂₄N₂O₄
• Degré de pureté: Min. 95%